Phase 1 study to Investigate the Safety and Immunogenicity of a Combined Respiratory Syncytial Virus/human Metapneumovirus/Parainfluenza Virus type 3 investigational mRNA Vaccine Candidate in Adult Participants Aged 60 Years and Older.
This study is being conducted at our Western Sydney, Central Coast and Brisbane sites.
Apply Now
A Phase 3 study investigating the efficacy and long-term safety of the experimental, modified inhaler with a climate friendly propellant HFA-152a in comparison to the currently approved inhaler with propellant HFA-134a in participants aged 18 years and over with diagnosed asthma.
This study is being being conducted at our Central Coast site
Apply Now
Research study investigating a new cholesterol medication on reducing cardiovascular events in individuals living with, or at risk of cardiovascular disease.
This study is being conducted at our Canberra site.
Apply Now
Looking for participants aged 18-70 years old that have suffered gout for more than 2 years to help investigate the use of the Investigational Product, a local, topically administered NSAID. The goal of topical administration within this study is that by targeting treatment to only the area of flare-up, the inflammation and pain of a gout flare can both be treated, while potentially reducing the systemic side effects of oral NSAIDs.
This study is only being conducted at our Central Coast site.
Apply Now
